{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T06:29:47Z","timestamp":1794810587215,"version":"4.9.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK138025"],"award-info":[{"award-number":["R01DK138025"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA257195"],"award-info":[{"award-number":["R01CA257195"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T33AI078892"],"award-info":[{"award-number":["T33AI078892"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["F30AI194739"],"award-info":[{"award-number":["F30AI194739"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["U01EB035521"],"award-info":[{"award-number":["U01EB035521"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"DOI":"10.1038\/s41587-026-03099-z","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:08:54Z","timestamp":1777453734000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression"],"prefix":"10.1038","author":[{"given":"Adam","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1966-0100","authenticated-orcid":false,"given":"Sophia","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0746-7629","authenticated-orcid":false,"given":"Filippo","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwitha","family":"Lakshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Phelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3089-7634","authenticated-orcid":false,"given":"Andrew","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Morla-Folch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham J. P.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Amabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Baccarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4481-7827","authenticated-orcid":false,"given":"Miriam","family":"Merad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0850-6730","authenticated-orcid":false,"given":"Joshua D.","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5786-0659","authenticated-orcid":false,"given":"Yizhou","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3670-8778","authenticated-orcid":false,"given":"Brian D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"3099_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/s41551-025-01511-8","volume":"9","author":"DD Kang","year":"2025","unstructured":"Kang, D. D. et al. Targeting and tracking mRNA lipid nanoparticles at the particle, transcript and protein level. Nat. Biomed. Eng. 9, 1591\u20131609 (2025).","journal-title":"Nat. Biomed. Eng."},{"key":"3099_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","volume":"65","author":"N Pardi","year":"2020","unstructured":"Pardi, N., Hogan, M. J. & Weissman, D. Recent advances in mRNA vaccine technology. Curr. Opin. Immunol. 65, 14\u201320 (2020).","journal-title":"Curr. Opin. Immunol."},{"key":"3099_CR3","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/S0140-6736(23)02444-3","volume":"403","author":"H Parhiz","year":"2024","unstructured":"Parhiz, H., Atochina-Vasserman, E. N. & Weissman, D. mRNA-based therapeutics: looking beyond COVID-19 vaccines. Lancet 403, 1192\u20131204 (2024).","journal-title":"Lancet"},{"key":"3099_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","volume":"8","author":"SA Dilliard","year":"2023","unstructured":"Dilliard, S. A. & Siegwart, D. J. Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs. Nat. Rev. Mater. 8, 282\u2013300 (2023).","journal-title":"Nat. Rev. Mater."},{"key":"3099_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0140-6736(25)00553-7","volume":"406","author":"O Pail","year":"2025","unstructured":"Pail, O., Lin, M. J., Anagnostou, T., Brown, B. D. & Brody, J. D. Cancer vaccines and the future of immunotherapy. Lancet 406, 189\u2013202 (2025).","journal-title":"Lancet"},{"key":"3099_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines\u2014a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"3099_CR7","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature18300","volume":"534","author":"LM Kranz","year":"2016","unstructured":"Kranz, L. M. et al. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy. Nature 534, 396\u2013401 (2016).","journal-title":"Nature"},{"key":"3099_CR8","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/nm1398","volume":"12","author":"BD Brown","year":"2006","unstructured":"Brown, B. D., Venneri, M. A., Zingale, A., Sergi Sergi, L. & Naldini, L. Endogenous microRNA regulation suppresses transgene expression in hematopoietic lineages and enables stable gene transfer. Nat. Med. 12, 585\u2013591 (2006).","journal-title":"Nat. Med."},{"key":"3099_CR9","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/nbt1372","volume":"25","author":"BD Brown","year":"2007","unstructured":"Brown, B. D. et al. Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 25, 1457\u20131467 (2007).","journal-title":"Nat. Biotechnol."},{"key":"3099_CR10","doi-asserted-by":"publisher","first-page":"4144","DOI":"10.1182\/blood-2007-03-078493","volume":"110","author":"BD Brown","year":"2007","unstructured":"Brown, B. D. et al. A microRNA-regulated lentiviral vector mediates stable correction of hemophilia B mice. Blood 110, 4144\u20134152 (2007).","journal-title":"Blood"},{"key":"3099_CR11","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrg2628","volume":"10","author":"BD Brown","year":"2009","unstructured":"Brown, B. D. & Naldini, L. Exploiting and antagonizing microRNA regulation for therapeutic and experimental applications. Nat. Rev. Genet. 10, 578\u2013585 (2009).","journal-title":"Nat. Rev. Genet."},{"key":"3099_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.omtn.2018.12.007","volume":"14","author":"J Lockhart","year":"2019","unstructured":"Lockhart, J., Canfield, J., Mong, E. F., VanWye, J. & Totary-Jain, H. Nucleotide modification alters microRNA-dependent silencing of microRNA switches. Mol. Ther. Nucleic Acids 14, 339\u2013350 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3099_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nbt.3301","volume":"33","author":"L Wroblewska","year":"2015","unstructured":"Wroblewska, L. et al. Mammalian synthetic circuits with RNA binding proteins delivered by RNA. Nat. Biotechnol. 33, 839\u2013841 (2015).","journal-title":"Nat. Biotechnol."},{"key":"3099_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/nat.2018.0734","volume":"28","author":"R Jain","year":"2018","unstructured":"Jain, R. et al. MicroRNAs enable mRNA therapeutics to selectively program cancer cells to self-destruct. Nucleic Acid Ther. 28, 285\u2013296 (2018).","journal-title":"Nucleic Acid Ther."},{"key":"3099_CR15","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/j.cell.2007.04.040","volume":"129","author":"P Landgraf","year":"2007","unstructured":"Landgraf, P. et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401\u20131414 (2007).","journal-title":"Cell"},{"key":"3099_CR16","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1038\/nm.1776","volume":"14","author":"EJ Kelly","year":"2008","unstructured":"Kelly, E. J., Hadac, E. M., Greiner, S. & Russell, S. J. Engineering microRNA responsiveness to decrease virus pathogenicity. Nat. Med. 14, 1278\u20131283 (2008).","journal-title":"Nat. Med."},{"key":"3099_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/mt.2014.177","volume":"23","author":"L Mazzacurati","year":"2015","unstructured":"Mazzacurati, L. et al. Use of miRNA response sequences to block off-target replication and increase the safety of an unattenuated, glioblastoma-targeted oncolytic HSV. Mol. Ther. 23, 99\u2013107 (2015).","journal-title":"Mol. Ther."},{"key":"3099_CR18","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.stem.2015.04.005","volume":"16","author":"K Miki","year":"2015","unstructured":"Miki, K. et al. Efficient detection and purification of cell populations using synthetic microRNA switches. Cell Stem Cell 16, 699\u2013711 (2015).","journal-title":"Cell Stem Cell"},{"key":"3099_CR19","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1126\/science.ade6967","volume":"381","author":"L Breda","year":"2023","unstructured":"Breda, L. et al. In vivo hematopoietic stem cell modification by mRNA delivery. Science 381, 436\u2013443 (2023).","journal-title":"Science"},{"key":"3099_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.immuni.2005.06.008","volume":"23","author":"K Karik\u00f3","year":"2005","unstructured":"Karik\u00f3, K., Buckstein, M., Ni, H. & Weissman, D. Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23, 165\u2013175 (2005).","journal-title":"Immunity"},{"key":"3099_CR21","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833\u20131840 (2008).","journal-title":"Mol. Ther."},{"key":"3099_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaa070","volume":"48","author":"CJC Parr","year":"2020","unstructured":"Parr, C. J. C. et al. N1-Methylpseudouridine substitution enhances the performance of synthetic mRNA switches in cells. Nucleic Acids Res. 48, e35 (2020).","journal-title":"Nucleic Acids Res."},{"key":"3099_CR23","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/s41590-021-00944-y","volume":"22","author":"SA Rose","year":"2021","unstructured":"Rose, S. A. et al. A microRNA expression and regulatory element activity atlas of the mouse immune system. Nat. Immunol. 22, 914\u2013927 (2021).","journal-title":"Nat. Immunol."},{"key":"3099_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","volume":"15","author":"KJ Hassett","year":"2019","unstructured":"Hassett, K. J. et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. Ther. Nucleic Acids 15, 1\u201311 (2019).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"3099_CR25","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/nmeth.2078","volume":"9","author":"G Mullokandov","year":"2012","unstructured":"Mullokandov, G. et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat. Methods 9, 840\u2013846 (2012).","journal-title":"Nat. Methods"},{"key":"3099_CR26","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/nri1845","volume":"6","author":"C Reis e Sousa","year":"2006","unstructured":"Reis e Sousa, C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476\u2013483 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"3099_CR27","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1073\/pnas.0610731104","volume":"104","author":"RM O\u2019Connell","year":"2007","unstructured":"O\u2019Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G. & Baltimore, D. MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl Acad. Sci. USA 104, 1604\u20131609 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3099_CR28","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s12195-025-00859-w","volume":"18","author":"LM Santiago","year":"2025","unstructured":"Santiago, L. M. et al. WNT7A mRNA lipid nanoparticles promote muscle hypertrophy and reduce fatty infiltration. Cell. Mol. Bioeng. 18, 387\u2013401 (2025).","journal-title":"Cell. Mol. Bioeng."},{"key":"3099_CR29","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","volume":"3","author":"KE Lindsay","year":"2019","unstructured":"Lindsay, K. E. et al. Visualization of early events in mRNA vaccine delivery in non-human primates via PET-CT and near-infrared imaging. Nat. Biomed. Eng. 3, 371\u2013380 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"3099_CR30","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR\u2013Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"3099_CR31","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","volume":"55","author":"R Verbeke","year":"2022","unstructured":"Verbeke, R., Hogan, M. J., Lor\u00e9, K. & Pardi, N. Innate immune mechanisms of mRNA vaccines. Immunity 55, 1993\u20132005 (2022).","journal-title":"Immunity"},{"key":"3099_CR32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3858\/emm.2009.41.2.008","volume":"41","author":"K Shortman","year":"2009","unstructured":"Shortman, K., Lahoud, M. H. & Caminschi, I. Improving vaccines by targeting antigens to dendritic cells. Exp. Mol. Med. 41, 61\u201366 (2009).","journal-title":"Exp. Mol. Med."},{"key":"3099_CR33","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","volume":"54","author":"M-G Alameh","year":"2021","unstructured":"Alameh, M.-G. et al. Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses. Immunity 54, 2877\u20132892 (2021).","journal-title":"Immunity"},{"key":"3099_CR34","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","volume":"23","author":"S Tahtinen","year":"2022","unstructured":"Tahtinen, S. et al. IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines. Nat. Immunol. 23, 532\u2013542 (2022).","journal-title":"Nat. Immunol."},{"key":"3099_CR35","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1016\/j.immuni.2023.11.009","volume":"56","author":"BD Brown","year":"2023","unstructured":"Brown, B. D., Fauci, A. S., Belkaid, Y. & Merad, M. RNA vaccines: a transformational advance. Immunity 56, 2665\u20132669 (2023).","journal-title":"Immunity"},{"key":"3099_CR36","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/2159-8290.CD-20-0756","volume":"11","author":"R Upadhyay","year":"2021","unstructured":"Upadhyay, R. et al. A critical role for Fas-mediated off-target tumor killing in T-cell immunotherapy. Cancer Discov. 11, 599\u2013613 (2021).","journal-title":"Cancer Discov."},{"key":"3099_CR37","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1038\/s41591-023-02612-0","volume":"29","author":"A Mackensen","year":"2023","unstructured":"Mackensen, A. et al. CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. Nat. Med. 29, 2844\u20132853 (2023).","journal-title":"Nat. Med."},{"key":"3099_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T. et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat. Med. 25, 249\u2013254 (2019).","journal-title":"Nat. Med."},{"key":"3099_CR39","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","volume":"25","author":"DL Wagner","year":"2019","unstructured":"Wagner, D. L. et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat. Med. 25, 242\u2013248 (2019).","journal-title":"Nat. Med."},{"key":"3099_CR40","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/nbt.3386","volume":"33","author":"J Agudo","year":"2015","unstructured":"Agudo, J. et al. GFP-specific CD8 T cells enable targeted cell depletion and visualization of T-cell interactions. Nat. Biotechnol. 33, 1287\u20131292 (2015).","journal-title":"Nat. Biotechnol."},{"key":"3099_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232314563","volume":"23","author":"K Teppert","year":"2022","unstructured":"Teppert, K. et al. Joining forces for cancer treatment: from \u2018TCR versus CAR\u2019 to \u2018TCR and CAR. Int. J. Mol. Sci. 23, 14563 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"3099_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abe2606","volume":"14","author":"AI Salter","year":"2021","unstructured":"Salter, A. I. et al. Comparative analysis of TCR and CAR signaling informs CAR designs with superior antigen sensitivity and in vivo function. Sci. Signal. 14, eabe2606 (2021).","journal-title":"Sci. Signal."},{"key":"3099_CR43","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.4049\/jimmunol.1700236","volume":"200","author":"DT Harris","year":"2018","unstructured":"Harris, D. T. et al. Comparison of T cell activities mediated by human TCRs and CARs that use the same recognition domains. J. Immunol. 200, 1088\u20131100 (2018).","journal-title":"J. Immunol."},{"key":"3099_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101033","volume":"297","author":"N Anikeeva","year":"2021","unstructured":"Anikeeva, N. et al. Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs. J. Biol. Chem. 297, 101033 (2021).","journal-title":"J. Biol. Chem."},{"key":"3099_CR45","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S1074-7613(00)80483-5","volume":"4","author":"Y Sykulev","year":"1996","unstructured":"Sykulev, Y., Joo, M., Vturina, I., Tsomides, T. J. & Eisen, H. N. Evidence that a single peptide\u2013MHC complex on a target cell can elicit a cytolytic T cell response. Immunity 4, 565\u2013571 (1996).","journal-title":"Immunity"},{"key":"3099_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.immuni.2018.02.001","volume":"48","author":"J Agudo","year":"2018","unstructured":"Agudo, J. et al. Quiescent tissue stem cells evade immune surveillance. Immunity 48, 271\u2013285 (2018).","journal-title":"Immunity"},{"key":"3099_CR47","doi-asserted-by":"publisher","first-page":"12117","DOI":"10.1073\/pnas.1206039109","volume":"109","author":"RA Langlois","year":"2012","unstructured":"Langlois, R. A., Varble, A., Chua, M. A., Garc\u00eda-Sastre, A. & tenOever, B. R. Hematopoietic-specific targeting of influenza A virus reveals replication requirements for induction of antiviral immune responses. Proc. Natl Acad. Sci. USA 109, 12117\u201312122 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3099_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002572","volume":"8","author":"A Smed-S\u00f6rensen","year":"2012","unstructured":"Smed-S\u00f6rensen, A. et al. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog. 8, e1002572 (2012).","journal-title":"PLoS Pathog."},{"key":"3099_CR49","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0165-5728(03)00093-6","volume":"138","author":"H Wiendl","year":"2003","unstructured":"Wiendl, H. et al. Antigen processing and presentation in human muscle: cathepsin S is critical for MHC class II expression and upregulated in inflammatory myopathies. J. Neuroimmunol. 138, 132\u2013143 (2003).","journal-title":"J. Neuroimmunol."},{"key":"3099_CR50","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.4161\/hv.25893","volume":"9","author":"C Coban","year":"2013","unstructured":"Coban, C., Kobiyama, K., Jounai, N., Tozuka, M. & Ishii, K. J. DNA vaccines: a simple DNA sensing matter? Hum. Vaccin. Immunother. 9, 2216\u20132221 (2013).","journal-title":"Hum. Vaccin. Immunother."},{"key":"3099_CR51","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.omtm.2020.03.008","volume":"17","author":"Y-Y Lin","year":"2020","unstructured":"Lin, Y.-Y. et al. Skeletal muscle is an antigen reservoir in integrase-defective lentiviral vector-induced long-term immunity. Mol. Ther. Methods Clin. Dev. 17, 532\u2013544 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"3099_CR52","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/hmg\/1.6.363","volume":"1","author":"JA Wolff","year":"1992","unstructured":"Wolff, J. A., Ludtke, J. J., Acsadi, G., Williams, P. & Jani, A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum. Mol. Genet. 1, 363\u2013369 (1992).","journal-title":"Hum. Mol. Genet."},{"key":"3099_CR53","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1177\/096368979600500308","volume":"5","author":"RJ Bartlett","year":"1996","unstructured":"Bartlett, R. J. et al. Long-term expression of a fluorescent reporter gene via direct injection of plasmid vector into mouse skeletal muscle: comparison of human creatine kinase and CMV promoter expression levels in vivo. Cell Transplant. 5, 411\u2013419 (1996).","journal-title":"Cell Transplant."},{"key":"3099_CR54","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1006\/viro.1999.9795","volume":"260","author":"D Loirat","year":"1999","unstructured":"Loirat, D. et al. Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses. Virology 260, 74\u201383 (1999).","journal-title":"Virology"},{"key":"3099_CR55","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ymthe.2025.10.034","volume":"34","author":"C Wang","year":"2026","unstructured":"Wang, C., Cheng, X., Cheng, K. & Yuan, F. Extracellular vesicles are key mediators for direct antigen transport to draining lymph nodes. Mol. Ther. 34, 606\u2013619 (2026).","journal-title":"Mol. Ther."},{"key":"3099_CR56","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/156652309787909490","volume":"9","author":"P LoDuca","year":"2009","unstructured":"LoDuca, P., Hoffman, B. & Herzog, R. Hepatic gene transfer as a means of tolerance induction to transgene products. Curr. Gene Ther. 9, 104\u2013114 (2009).","journal-title":"Curr. Gene Ther."},{"key":"3099_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/mtm.2014.13","volume":"1","author":"BK Sack","year":"2014","unstructured":"Sack, B. K., Herzog, R. W., Terhorst, C. & Markusic, D. M. Development of gene transfer for induction of antigen-specific tolerance. Mol. Ther. Methods Clin. Dev. 1, 14013 (2014).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"3099_CR58","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.3389\/fimmu.2019.02525","volume":"10","author":"M Zheng","year":"2019","unstructured":"Zheng, M. & Tian, Z. Liver-mediated adaptive immune tolerance. Front. Immunol. 10, 2525 (2019).","journal-title":"Front. Immunol."},{"key":"3099_CR59","doi-asserted-by":"publisher","first-page":"16735","DOI":"10.1073\/pnas.1112251108","volume":"108","author":"V Benseler","year":"2011","unstructured":"Benseler, V. et al. Hepatocyte entry leads to degradation of autoreactive CD8 T cells. Proc. Natl Acad. Sci. USA 108, 16735\u201316740 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3099_CR60","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.ymthe.2017.02.014","volume":"25","author":"SRP Kumar","year":"2017","unstructured":"Kumar, S. R. P., Hoffman, B. E., Terhorst, C., de Jong, Y. P. & Herzog, R. W. The balance between CD8+ T cell-mediated clearance of AAV-encoded antigen in the liver and tolerance is dependent on the vector dose. Mol. Ther. 25, 880\u2013891 (2017).","journal-title":"Mol. Ther."},{"key":"3099_CR61","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1126\/science.aay5967","volume":"367","author":"K Reinhard","year":"2020","unstructured":"Reinhard, K. et al. An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumors. Science 367, 446\u2013453 (2020).","journal-title":"Science"},{"key":"3099_CR62","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/j.immuni.2021.06.018","volume":"54","author":"AT DiPiazza","year":"2021","unstructured":"DiPiazza, A. T. et al. COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge. Immunity 54, 1869\u20131882 (2021).","journal-title":"Immunity"},{"key":"3099_CR63","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41586-020-2622-0","volume":"586","author":"KS Corbett","year":"2020","unstructured":"Corbett, K. S. et al. SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature 586, 567\u2013571 (2020).","journal-title":"Nature"},{"key":"3099_CR64","doi-asserted-by":"publisher","first-page":"14604","DOI":"10.1073\/pnas.1209367109","volume":"109","author":"AJ Geall","year":"2012","unstructured":"Geall, A. J. et al. Nonviral delivery of self-amplifying RNA vaccines. Proc. Natl Acad. Sci. USA 109, 14604\u201314609 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"3099_CR65","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41587-022-01393-0","volume":"41","author":"R Chen","year":"2023","unstructured":"Chen, R. et al. Engineering circular RNA for enhanced protein production. Nat. Biotechnol. 41, 262\u2013272 (2023).","journal-title":"Nat. Biotechnol."},{"key":"3099_CR66","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/978-1-0716-3770-8_7","volume":"2786","author":"M Vadovics","year":"2024","unstructured":"Vadovics, M., Muramatsu, H., S\u00e1rk\u00f6zy, A. & Pardi, N. Production and evaluation of nucleoside-modified mRNA vaccines for infectious diseases. Methods Mol. Biol. 2786, 167\u2013181 (2024).","journal-title":"Methods Mol. Biol."},{"key":"3099_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202004452","volume":"32","author":"C Zeng","year":"2020","unstructured":"Zeng, C. et al. Leveraging mRNA sequences and nanoparticles to deliver SARS-CoV-2 antigens in vivo. Adv. Mater. 32, e2004452 (2020).","journal-title":"Adv. Mater."},{"key":"3099_CR68","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061338","volume":"8","author":"ML Davila","year":"2013","unstructured":"Davila, M. L., Kloss, C. C., Gunset, G. & Sadelain, M. CD19 CAR-targeted T cells induce long-term remission and B cell aplasia in an immunocompetent mouse model of B cell acute lymphoblastic leukemia. PLoS ONE 8, e61338 (2013).","journal-title":"PLoS ONE"},{"key":"3099_CR69","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1158\/2326-6066.CIR-21-1075","volume":"10","author":"AR S\u00e1nchez-Paulete","year":"2022","unstructured":"S\u00e1nchez-Paulete, A. R. et al. Targeting macrophages with CAR T cells delays solid tumor progression and enhances antitumor immunity. Cancer Immunol. Res. 10, 1354\u20131369 (2022).","journal-title":"Cancer Immunol. Res."},{"key":"3099_CR70","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.cell.2022.02.015","volume":"185","author":"M Dhainaut","year":"2022","unstructured":"Dhainaut, M. et al. Spatial CRISPR genomics identifies regulators of the tumor microenvironment. Cell 185, 1223\u20131239 (2022).","journal-title":"Cell"},{"key":"3099_CR71","doi-asserted-by":"publisher","first-page":"e31657","DOI":"10.7554\/eLife.31657","volume":"7","author":"JR Lin","year":"2018","unstructured":"Lin, J. R. et al. Highly multiplexed immunofluorescence imaging of human tissues and tumors using t-CyCIF and conventional optical microscopes. eLife 7, e31657 (2018).","journal-title":"eLife"},{"key":"3099_CR72","doi-asserted-by":"publisher","first-page":"7492","DOI":"10.1016\/j.cell.2024.10.006","volume":"187","author":"G Mollaoglu","year":"2024","unstructured":"Mollaoglu, G. et al. Ovarian cancer-derived IL-4 promotes immunotherapy resistance. Cell 187, 7492\u20137510 (2024).","journal-title":"Cell"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03099-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03099-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03099-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T09:08:55Z","timestamp":1777453735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-026-03099-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":72,"alternative-id":["3099"],"URL":"https:\/\/doi.org\/10.1038\/s41587-026-03099-z","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.D.B. has a patent on the use of miRTs in gene vectors, which is not related to this work. B.D.B. is on the scientific advisory boards of Asgard Therapeutics, Noetik and Navexio and consults for Merck. Y.D. is a cofounder and holds equity in Immunanoengineering Therapeutics. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}